35 results
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
, and there is a risk that AMTI’s existing NOLs could expire unused and be unavailable to offset future income tax liabilities, which could adversely affect … ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change taxable income or taxes may be limited
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
Tax ruling, (F) apply for any Tax incentive program or (G) surrender any right to claim a material refund of Taxes or an offset or other reduction
8-K
EX-2.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
a material refund of Taxes or an offset or other reduction in liability for Taxes or refund;
(xi) (A) enter into any Contract that would have been
8-K
EX-10.1
h4w9da6 2f8kr
24 Jul 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
rl255u
7 Nov 22
Applied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:07pm
S-3
s5scuhhwy8 ev4q8
11 Mar 22
Shelf registration
5:03pm
8-K
EX-99.1
49qjkvq8qtfx
10 Nov 21
Applied Molecular Transport Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
ka05vllh6ul
10 Aug 21
Applied Molecular Transport Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
r194 woil22fkp2r8
13 May 21
Applied Molecular Transport Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:05pm
DEFA14A
udagqhqmmz
7 Apr 21
Additional proxy soliciting materials
4:08pm